Skip to main content
. 2022 Mar 8;27(6):1762. doi: 10.3390/molecules27061762

Figure 6.

Figure 6

Relationships between drug-resistance-related proteins and overall survival (OS) in breast cancer patients. The log-rank test of overall survival rate of 194 upregulated proteins (a) and 294 downregulated proteins (b) in TCGA-BRCA pan-cancer (x-axis) and Metabric cohorts (y-axis). The highly significant log-rank p-value in both cohorts was indicated with red (a) and blue (b). Log-rank analysis of overall survival according to expression level of PLXNB2 (c) and ACOX3 (d) in patients treated with chemotherapy from Metabric.